{
    "clinical_study": {
        "@rank": "104251", 
        "acronym": "UltraHeal", 
        "arm_group": [
            {
                "arm_group_label": "Ultrasound debridement", 
                "arm_group_type": "Experimental", 
                "description": "Participants receiving ultrasound assisted debridement in addition to best practice wound care."
            }, 
            {
                "arm_group_label": "Best Practice wound care", 
                "arm_group_type": "Active Comparator", 
                "description": "Participants receiving best practice wound care alone"
            }
        ], 
        "brief_summary": {
            "textblock": "The UltraHeal Study is a randomized controlled trial to compare healing response of low\n      frequency contact ultrasonic-assisted debridement in addition to best practice wound care to\n      best practice wound care alone in a Vascular Surgery Clinic patient population with wounds\n      of the lower extremity."
        }, 
        "brief_title": "Efficacy Study of Ultrasound-Assisted Debridement to Influence Wound Healing", 
        "completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "WOUNDS", 
        "detailed_description": {
            "textblock": "The study will also investigate the bacterial tissue burden and protease activity to provide\n      further insight into the infection and inflammation aspects of healing barriers in a\n      challenging population."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Persons with lower extremity wound referred to vascular surgery service.\n\n          -  Full thickness wound below the knee with surface area of at least 1cm2.\n\n          -  Age >18 years\n\n          -  English speaking\n\n          -  Ulcer of known etiology including diabetic foot wounds, and arterial or venous leg\n             ulcers\n\n          -  Willing and able to adhere to 12 week study protocol that includes attending weekly\n             clinic appointments, and wearing prescribed footwear or compression therapy\n\n        Exclusion Criteria:\n\n          -  Leg wounds due to inflammatory conditions (e.g.  pyoderma gangrenosum, vasculitis),\n             malignancy, or other unknown etiologies.\n\n          -  Severe arterial insufficiency: Absence of pedal pulses combined with     Ankle\n             Brachial Index   \u2264 0.3,  Toe Pressure  \u226420, or Trans Cutaneous Oxygen Measure \u226420\n\n          -  Presence of acute limb threatening infection\n\n          -  Vascular surgery planned within next 3 months\n\n          -  Exposed vascular graft or blood vessel, bone or tendon in the base of the wound.\n\n          -  Currently receiving advanced wound therapy treatments: Hyperbaric therapy, biological\n             dressings [collagen or extracellular matrix dressings].\n\n          -  Increased likelihood of an adverse reaction to ultrasonic debridement due to:\n\n          -  Excessive wound pain (>5 VAS scale) or patient described intolerable\n\n          -  Allergy to topical anesthetic (lidocaine)\n\n          -  Individuals who have factors/circumstances that are known to limit their ability to\n             demonstrate healing in 4 weeks.\n\n        For example:\n\n          -  medically unstable or palliative medical status\n\n          -  poor nutritional status (low serum albumin < 15),\n\n          -  anemia (Hb < 75 mg/dl),\n\n          -  taking immunosuppressant medication (prednisone, chemotherapy; transplant\n             anti-rejection medication),\n\n          -  Individuals with medical conditions that contraindicate the use of ultrasound energy\n\n          -  Cardiac pacemaker or defibrillator\n\n          -  Excessive bleeding tendency (> 5 mins post debridement) or identified coagulopathic\n             disorders\n\n          -  Exposed bone in the wound base\n\n          -  Untreated osteomyelitis"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "82", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01973361", 
            "org_study_id": "20130152-01H"
        }, 
        "intervention": [
            {
                "arm_group_label": "Ultrasound debridement", 
                "description": "Ultrasound-assisted wound debridement with saline irrigant applied for 5 - 15 minutes until visible and removable non-viable appearance tissue is removed to reveal a healthy appearance wound bed.", 
                "intervention_name": "Ultrasound debridement", 
                "intervention_type": "Device", 
                "other_name": "Misonix Sonic One Ultrasound Wound Care System"
            }, 
            {
                "arm_group_label": "Best Practice wound care", 
                "description": "Participants will receive moist wound care with addition of silver alginate dressing for visual cues of infection.", 
                "intervention_name": "Best practice wound care", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Wounds", 
            "Lower extremity", 
            "Diabetes", 
            "Arterial Insufficiency", 
            "Debridement", 
            "Low frequency ultrasound", 
            "Contact ultrasound", 
            "Wound clinic", 
            "Wound bed preparation", 
            "Wound infection", 
            "Chronic wound inflammation"
        ], 
        "lastchanged_date": "April 2, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Ottawa", 
                    "country": "Canada", 
                    "state": "Ontario", 
                    "zip": "K1Y 4E9"
                }, 
                "name": "The Ottawa Hospital Wound Healing Centre"
            }, 
            "investigator": [
                {
                    "last_name": "Christine A. Murphy, MClSc PhD(c)", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Tim Brandys, MD MEd FRCSC", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Gregory W. Rose, MSc MD FRCPC", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Pamela E. Houghton, BSc PhD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized Controlled Trial to Investigate if Application of Low Frequency Ultrasound-assisted Debridement May Improve Healing and Infection Outcomes for the Person With Vasculopathy and Recalcitrant Wounds of the Lower Extremity", 
        "overall_contact": {
            "email": "chrmurphy@toh.on.ca", 
            "last_name": "Christine A. Murphy, MClSc PhD(c)", 
            "phone": "613 798-5555", 
            "phone_ext": "79494"
        }, 
        "overall_contact_backup": {
            "email": "tbrandys@toh.on.ca", 
            "last_name": "Tim Brandys, MD MEd FRCSC", 
            "phone": "613 798-5555", 
            "phone_ext": "13804"
        }, 
        "overall_official": {
            "affiliation": "The Ottawa Hospital", 
            "last_name": "Christine A. Murphy, MClSc PhD(c)", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Canada: Ethics Review Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The wound surface area will be measured weekly once treatment is initiated, with a final measurement 12 weeks after initiation of therapy.", 
            "measure": "Change in wound surface area", 
            "safety_issue": "No", 
            "time_frame": "Weekly for 4 weeks then at 12 weeks."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01973361"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "A wound swab to test for elevated protease activity will be obtained before treatment and at week5 (after the 4 weekly treatments), and then again at week 12 to ascertain the immediate and sustained impact on inflammatory aspects of wound healing.", 
                "measure": "Protease activity", 
                "safety_issue": "No", 
                "time_frame": "Pre-treatment, post treatment at weeks 5 and weeks then at 12 weeks."
            }, 
            {
                "description": "A tissue culture to test for elevated bacterial activity and species identification will be obtained before treatment and at week 5 (after the 4 weekly treatments), and then again at week 12 to ascertain the immediate and sustained impact on infection aspects of wound healing", 
                "measure": "Bacterial burden", 
                "safety_issue": "No", 
                "time_frame": "Pre-treatment, week 5 and week 12"
            }, 
            {
                "description": "We will count the number of wounds that have healed and have not healed for each group and compare to ascertain if the therapy improves healing.", 
                "measure": "Number of wounds healed", 
                "safety_issue": "No", 
                "time_frame": "Throughout duration of the study"
            }
        ], 
        "source": "Ottawa Hospital Research Institute", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ottawa Hospital Research Institute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}